CLARRISA HAMANN: Open Payments
NPI 1255542718 · HIGHLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,717 in 87 payments from 20 companies in 2025. Trend: 2023 $2,015 · 2024 $2,173 · 2025 $2,717
Food & beverage: $2,717
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $479 |
| Novartis Pharmaceuticals Corporation | 17 | $447 |
| AOP Health US, LLC | 1 | $391 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $358 |
| BridgeBio Pharma, Inc. | 9 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $174 |
| Edwards Lifesciences Corporation | 1 | $161 |
| Novo Nordisk Inc | 4 | $102 |
| AtriCure, Inc. | 1 | $69 |
| Abbott Laboratories | 2 | $57 |
Products named: LEQVIO, Rapiblyk, Kerendia, WAINUA, FARXIGA, Attruby, JARDIANCE, PASCAL.
Industry payments across IL — which companies pay providers there.
